These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 27156733)

  • 1. N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5.
    Zou S; Toh JD; Wong KH; Gao YG; Hong W; Woon EC
    Sci Rep; 2016 May; 6():25677. PubMed ID: 27156733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct RNA
    Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of substrate recognition and N6-methyladenosine demethylation revealed by crystal structures of ALKBH5-RNA complexes.
    Kaur S; Tam NY; McDonough MA; Schofield CJ; Aik WS
    Nucleic Acids Res; 2022 Apr; 50(7):4148-4160. PubMed ID: 35333330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Flavin Mononucleotide as a Cell-Active Artificial N
    Xie LJ; Yang XT; Wang RL; Cheng HP; Li ZY; Liu L; Mao L; Wang M; Cheng L
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):5028-5032. PubMed ID: 30756480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA m6A modification, signals for degradation or stabilisation?
    Wei G
    Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates.
    Zhang X; Wei LH; Wang Y; Xiao Y; Liu J; Zhang W; Yan N; Amu G; Tang X; Zhang L; Jia G
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2919-2924. PubMed ID: 30718435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy.
    Xiang M; Liu W; Tian W; You A; Deng D
    Epigenomics; 2020 May; 12(9):801-809. PubMed ID: 32515221
    [No Abstract]   [Full Text] [Related]  

  • 14. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
    Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
    Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
    Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
    Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased
    Luo Q; Gao Y; Zhang L; Rao J; Guo Y; Huang Z; Li J
    Biomed Res Int; 2020; 2020():5735279. PubMed ID: 32884942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic RNA modifications in disease.
    Klungland A; Dahl JA
    Curr Opin Genet Dev; 2014 Jun; 26():47-52. PubMed ID: 25005745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylases in tumors and the tumor microenvironment: Key modifiers of N
    Guo J; Zhao L; Duan M; Yang Z; Zhao H; Liu B; Wang Y; Deng L; Wang C; Jiang X; Jiang X
    Biomed Pharmacother; 2024 May; 174():116479. PubMed ID: 38537580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.